₩27,000.00 ($20.09)

+950.00 (+3.65%)

Weekly Expected Move ±8.5%

₩22406 ₩24703 ₩27000 ₩29297 ₩31594

KOE · Healthcare · Medical - Specialties · Tech Score Buy · Power 66 · ₩1.03T mcap · 25M float · 1.16% daily turnover

Revenue

$48.2B +494.7% ▲

5Y CAGR: +137.4%

Gross Profit

$34.2B +895.2% ▲

Operating Income

$16.3B +288.1% ▲

Net Income

$16.2B +282.4% ▲

EPS (Diluted)

$425.92 +269.8% ▲

EBITDA

$17.6B +342.8% ▲

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$1.4B	$1.2B	$1.9B	$8.1B	$48.2B
YoY Growth	+116.8%	-16.8%	+63.5%	+329.7%	+494.7%
Cost of Revenue	$1.5B	$1.7B	$2.7B	$4.7B	$14.0B
Gross Profit	-$143M	-$551M	-$824M	$3.4B	$34.2B
Gross Margin	-10.3%	-47.8%	-43.7%	42.4%	71.0%
R&D Expenses	$1.4B	$2.8B	$3.5B	$4.1B	$0
SG&A Expenses	$1.2B	$2.0B	$2.4B	$4.0B	$0
Operating Expenses	$4.2B	$7.4B	$9.0B	$12.1B	$17.9B
Operating Income	-$4.4B	-$8.0B	-$9.8B	-$8.7B	$16.3B
Operating Margin	-316.6%	-693.0%	-520.1%	-107.2%	33.9%
Interest Expense	$132M	$93M	$210M	$391M	$238M
Income Before Tax	-$4.4B	-$8.0B	-$9.9B	-$8.8B	$16.2B
Tax Expense	$0	$0	$0	$93M	-$11M
Net Income	-$4.4B	-$8.0B	-$9.9B	-$8.9B	$16.2B
Net Margin	-319.6%	-692.9%	-526.1%	-109.5%	33.6%
EPS (Diluted)	$-410.98	$-741.00	$-905.00	$-752.44	$425.92
EBITDA	-$4.0B	-$7.4B	-$8.7B	-$7.3B	$17.6B
Shares Outstanding	11M	11M	11M	12M	38M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$984M	$5.5B	$4.1B	$8.0B	$15.7B	$20.4B	$32.5B	$28.4B
Cost of Revenue	$1.0B	$1.9B	$1.4B	$2.2B	$4.6B	$5.2B	$11.9B	$8.5B
Gross Profit	-$36M	$3.6B	$2.6B	$5.7B	$11.1B	$15.2B	$20.6B	$19.8B
Gross Margin	-3.7%	65.6%	64.7%	72.2%	70.5%	74.5%	63.3%	69.9%
R&D Expenses	$0	$839M	$1.1B	$1.2B	$1.2B	$1.1B	$2.2B	$1.7B
SG&A Expenses	$1.1B	$1.4B	$993M	$1.6B	$1.4B	$1.5B	$1.9B	$2.2B
Operating Expenses	$3.5B	$3.3B	$3.2B	$4.3B	$4.4B	$6.5B	$6.7B	$7.0B
Operating Income	-$3.5B	$328M	-$588M	$1.5B	$6.7B	$8.7B	$13.9B	$12.8B
Operating Margin	-359.1%	6.0%	-14.5%	18.7%	42.7%	42.6%	42.6%	45.2%
Interest Expense	$94M	$64M	$61M	$55M	$57M	$65M	$69M	$70M
Income Before Tax	-$3.5B	$374M	-$593M	$1.5B	$6.7B	$8.5B	$13.7B	$12.9B
Tax Expense	$0	$93M	$0	$0	$0	-$11M	$0	$0
Net Income	-$3.5B	$281M	-$593M	$1.5B	$6.7B	$8.6B	$13.7B	$13.0B
Net Margin	-350.9%	5.1%	-14.6%	18.9%	42.8%	41.9%	42.3%	45.7%
EPS (Diluted)	$-278.00	$22.37	$-47.00	$119.00	$177.67	$224.71	$361.36	$330.37
EBITDA	-$3.1B	$727M	-$246M	$1.7B	$7.1B	$9.1B	$14.3B	$13.3B
Shares Outstanding	12M	13M	13M	13M	38M	38M	38M	39M

458870.KQ KOE